Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11430)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jun 10, 2017 (publication date) through Nov 21, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Guo S, Contratto M, Miller G, Leichman L, Wu J. Immunotherapy in pancreatic cancer: Unleash its potential through novel combinations. World J Clin Oncol 2017; 8(3): 230-240 [PMID: 28638792 DOI: 10.5306/wjco.v8.i3.230] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v8/i3/230.htm |
| Number | Citing Articles |
| 1 |
Mehdi Chaib, Bilal B. Hafeez, Hassan Mandil, Deidre Daria, Ajeeth K. Pingili, Sonam Kumari, Mohammed Sikander, Vivek K. Kashyap, Guo-Yun Chen, Emmanuel Anning, Manish K. Tripathi, Sheema Khan, Stephen Behrman, Murali M. Yallapu, Meena Jaggi, Liza Makowski, Subhash C. Chauhan. Reprogramming of pancreatic adenocarcinoma immunosurveillance by a microbial probiotic siderophore. Communications Biology 2022; 5(1) doi: 10.1038/s42003-022-04102-4
|
| 2 |
Deepa Sharma, Evan McNabb, Niki Law, Aaron Cumal, Gregory J Czarnota. Ultrasound-stimulated microbubbles enhancement of fractionated radiation for tumor treatment. BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-10981-5
|
| 3 |
E. Capoluongo, P. Pisapia, U. Malapelle, G. Troncone. Liquid Biopsy. 2023; : 119 doi: 10.1016/B978-0-12-822703-9.00004-1
|
| 4 |
Harshul Pandit, Young K. Hong, Yan Li, Jack Rostas, Zachary Pulliam, Su Ping Li, Robert C. G. Martin. Evaluating the Regulatory Immunomodulation Effect of Irreversible Electroporation (IRE) in Pancreatic Adenocarcinoma. Annals of Surgical Oncology 2019; 26(3): 800 doi: 10.1245/s10434-018-07144-3
|
| 5 |
Chin-King Looi, Felicia Fei-Lei Chung, Chee-Onn Leong, Shew-Fung Wong, Rozita Rosli, Chun-Wai Mai. Therapeutic challenges and current immunomodulatory strategies in targeting the immunosuppressive pancreatic tumor microenvironment. Journal of Experimental & Clinical Cancer Research 2019; 38(1) doi: 10.1186/s13046-019-1153-8
|
| 6 |
Kanan Panchal, Rakesh Kumar Sahoo, Umesh Gupta, Akash Chaurasiya. Role of targeted immunotherapy for pancreatic ductal adenocarcinoma (PDAC) treatment: An overview. International Immunopharmacology 2021; 95: 107508 doi: 10.1016/j.intimp.2021.107508
|
| 7 |
Stephanie Berger, Sylvia Bochum, Dora Finkeisen, Antonella Schilliro, Frank Autschbach, Marc Bischof, Egbert Hagmueller, Philippe Lucien Pereira, Uwe Weickert, Bence Sipos, Saskia Biskup, Uwe Marc Martens. Sustainable Response of a Patient With Metastasized Pancreatic Cancer and a Hypermutational Phenotype to Immunotherapy. New Therapeutic Concept for a Rare Subtype?. JCO Precision Oncology 2018; (2): 1 doi: 10.1200/PO.18.00005
|
| 8 |
Jun Zhao, Zhilan Xiao, Tingting Li, Huiqin Chen, Ying Yuan, Y. Alan Wang, Cheng-Hui Hsiao, Diana S-L. Chow, Willem W. Overwijk, Chun Li. Stromal Modulation Reverses Primary Resistance to Immune Checkpoint Blockade in Pancreatic Cancer. ACS Nano 2018; 12(10): 9881 doi: 10.1021/acsnano.8b02481
|
| 9 |
Weiqing Jing, Donna McAllister, Emily P. Vonderhaar, Katie Palen, Matthew J. Riese, Jill Gershan, Bryon D. Johnson, Michael B. Dwinell. STING agonist inflames the pancreatic cancer immune microenvironment and reduces tumor burden in mouse models. Journal for ImmunoTherapy of Cancer 2019; 7(1) doi: 10.1186/s40425-019-0573-5
|
| 10 |
Javed Mahmood, Allen A. Alexander, Santanu Samanta, Shriya Kamlapurkar, Prerna Singh, Ali Saeed, France Carrier, Xuefang Cao, Hem D Shukla, Zeljko Vujaskovic. A Combination of Radiotherapy, Hyperthermia, and Immunotherapy Inhibits Pancreatic Tumor Growth and Prolongs the Survival of Mice. Cancers 2020; 12(4): 1015 doi: 10.3390/cancers12041015
|
| 11 |
Rannah Dabiri, Mamoon Ur Rashid, Osama Sherjeel Khan, Sundas Jehanzeb, Mohammad Alomari, Hammad Zafar, Effa Zahid, Asad Ur Rahman, Alvina Karam, Sarfraz Ahmad. Immune Landscape of Pancreatic Cancer Development and Drug Resistance. 2024; : 103 doi: 10.1016/B978-0-443-23523-8.00021-3
|
| 12 |
Bradley R. Hall, Andrew Cannon, Pranita Atri, Christopher S. Wichman, Lynette M. Smith, Apar K. Ganti, Chandrakanth Are, Aaron R. Sasson, Sushil Kumar, Surinder K. Batra. Advanced pancreatic cancer: a meta-analysis of clinical trials over thirty years. Oncotarget 2018; 9(27): 19396 doi: 10.18632/oncotarget.25036
|
| 13 |
Fatemeh Zahedipour, Khadijeh Jamialahmadi, Parvin Zamani, Mahmoud Reza Jaafari. Improving the efficacy of peptide vaccines in cancer immunotherapy. International Immunopharmacology 2023; 123: 110721 doi: 10.1016/j.intimp.2023.110721
|
| 14 |
Ines A. Batista, Sonia A. Melo. Exosomes and the Future of Immunotherapy in Pancreatic Cancer. International Journal of Molecular Sciences 2019; 20(3): 567 doi: 10.3390/ijms20030567
|
| 15 |
Alberto D’Angelo, Navid Sobhani, Giandomenico Roviello, Stefan Bagby, Deborah Bonazza, Cristina Bottin, Fabiola Giudici, Fabrizio Zanconati, Nicolo De Manzini, Alessandra Guglielmi, Daniele Generali, Ilse Rooman. Tumour infiltrating lymphocytes and immune-related genes as predictors of outcome in pancreatic adenocarcinoma. PLOS ONE 2019; 14(8): e0219566 doi: 10.1371/journal.pone.0219566
|
| 16 |
Jian-wei Xu, Lei Wang, Yu-gang Cheng, Guang-yong Zhang, San-yuan Hu, Bin Zhou, Han-xiang Zhan. Immunotherapy for pancreatic cancer: A long and hopeful journey. Cancer Letters 2018; 425: 143 doi: 10.1016/j.canlet.2018.03.040
|
| 17 |
Matthew Brown, Wanbin Zhang, Deyue Yan, Rajath Kenath, Le Le, He Wang, Daniel Delitto, David Ostrov, Keith Robertson, Chen Liu, Kien Pham, Andrei L. Gartel. The role of survivin in the progression of pancreatic ductal adenocarcinoma (PDAC) and a novel survivin-targeted therapeutic for PDAC. PLOS ONE 2020; 15(1): e0226917 doi: 10.1371/journal.pone.0226917
|
| 18 |
Magdalena Huber, Corinna U. Brehm, Thomas M. Gress, Malte Buchholz, Bilal Alashkar Alhamwe, Elke von Strandmann, Emily P. Slater, Jörg W. Bartsch, Christian Bauer, Matthias Lauth. The Immune Microenvironment in Pancreatic Cancer. International Journal of Molecular Sciences 2020; 21(19): 7307 doi: 10.3390/ijms21197307
|
| 19 |
Teresa Manzo, Boone M. Prentice, Kristin G. Anderson, Ayush Raman, Aislyn Schalck, Gabriela S. Codreanu, Carina B. Nava Lauson, Silvia Tiberti, Andrea Raimondi, Marissa A. Jones, Michelle Reyzer, Breanna M. Bates, Jeffrey M. Spraggins, Nathan H. Patterson, John A. McLean, Kunal Rai, Carlo Tacchetti, Sara Tucci, Jennifer A. Wargo, Simona Rodighiero, Karen Clise-Dwyer, Stacy D. Sherrod, Michael Kim, Nicholas E. Navin, Richard M. Caprioli, Philip D. Greenberg, Giulio Draetta, Luigi Nezi. Accumulation of long-chain fatty acids in the tumor microenvironment drives dysfunction in intrapancreatic CD8+ T cells. Journal of Experimental Medicine 2020; 217(8) doi: 10.1084/jem.20191920
|
| 20 |
Giorgia Mandili, Claudia Curcio, Sara Bulfamante, Laura Follia, Giulio Ferrero, Emanuela Mazza, Moitza Principe, Francesca Cordero, Maria Antonietta Satolli, Rosella Spadi, Andrea Evangelista, Daniele Giordano, Duy Viet, Paola Cappello, Francesco Novelli. In pancreatic cancer, chemotherapy increases antitumor responses to tumor-associated antigens and potentiates DNA vaccination. Journal for ImmunoTherapy of Cancer 2020; 8(2): e001071 doi: 10.1136/jitc-2020-001071
|
| 21 |
Evelien Schaafsma, Yiwei Yuan, Yanding Zhao, Chao Cheng. Computational STAT3 activity inference reveals its roles in the pancreatic tumor microenvironment. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-54791-x
|
| 22 |
Zhengze Lu, Yang Long, Yashi Wang, Xuhui Wang, Chunyu Xia, Man Li, Zhirong Zhang, Qin He. Phenylboronic acid modified nanoparticles simultaneously target pancreatic cancer and its metastasis and alleviate immunosuppression. European Journal of Pharmaceutics and Biopharmaceutics 2021; 165: 164 doi: 10.1016/j.ejpb.2021.05.014
|
| 23 |
Yixuan Zhou, Ingmar Niels Bastian, Mark D. Long, Michelle Dow, Weihua Li, Tao Liu, Rachael Katie Ngu, Laura Antonucci, Jian Yu Huang, Qui T. Phung, Xi-he Zhao, Sourav Banerjee, Xue-Jia Lin, Hongxia Wang, Brian Dang, Sylvia Choi, Daniel Karin, Hua Su, Mark H. Ellisman, Christina Jamieson, Marcus Bosenberg, Zhang Cheng, Johannes Haybaeck, Lukas Kenner, Kathleen M. Fisch, Richard Bourgon, Genevive Hernandez, Jennie R. Lill, Song Liu, Hannah Carter, Ira Mellman, Michael Karin, Shabnam Shalapour. Activation of NF-κB and p300/CBP potentiates cancer chemoimmunotherapy through induction of MHC-I antigen presentation. Proceedings of the National Academy of Sciences 2021; 118(8) doi: 10.1073/pnas.2025840118
|
| 24 |
Christian Vay, Shahrooz Babaei, Sami-Alexander Safi, Levent Dizdar, Alexander Rehders, Lena Haeberle, Christoph Roderburg, Sven H. Loosen, Irene Esposito, Wolfram T. Knoefel, Andreas Krieg. Clinicopathological and Prognostic Value of Survivin Expression in Surgically Resected Pancreatic Ductal Adenocarcinoma. Cancers 2022; 14(14): 3494 doi: 10.3390/cancers14143494
|
| 25 |
Albrecht Neesse, Christian Alexander Bauer, Daniel Öhlund, Matthias Lauth, Malte Buchholz, Patrick Michl, David A Tuveson, Thomas M Gress. Stromal biology and therapy in pancreatic cancer: ready for clinical translation?. Gut 2019; 68(1): 159 doi: 10.1136/gutjnl-2018-316451
|
| 26 |
Sami Ibrahimi, Sarbajit Mukherjee, Laith Alhyari, Erin Rubin, Raid Aljumaily. Spontaneous Regression of Metastatic Pancreatic Cancer. Pancreas 2019; 48(1): e4 doi: 10.1097/MPA.0000000000001193
|
| 27 |
Carmen Mota Reyes, Steffen Teller, Alexander Muckenhuber, Björn Konukiewitz, Okan Safak, Wilko Weichert, Helmut Friess, Güralp O. Ceyhan, Ihsan Ekin Demir. Neoadjuvant Therapy Remodels the Pancreatic Cancer Microenvironment via Depletion of Protumorigenic Immune Cells. Clinical Cancer Research 2020; 26(1): 220 doi: 10.1158/1078-0432.CCR-19-1864
|
| 28 |
Lennart Versemann, Elisabeth Hessmann, Maria Ulisse. Epigenetic Therapeutic Strategies to Target Molecular and Cellular Heterogeneity in Pancreatic Cancer. Visceral Medicine 2022; 38(1): 11 doi: 10.1159/000519859
|
| 29 |
Miquell O. Miller, Purna C. Kashyap, Sarah L. Becker, Ryan M. Thomas, Richard A. Hodin, George Miller, Mautin Hundeyin, Smruti Pushalkar, Deirdre Cohen, Deepak Saxena, Benjamin D. Shogan, Gareth J. Morris-Stiff. SSAT State-of-the-Art Conference: Advancements in the Microbiome. Journal of Gastrointestinal Surgery 2021; 25(7): 1885 doi: 10.1007/s11605-020-04551-4
|
| 30 |
Federico Nichetti, Antonio Marra, Francesca Corti, Alessandro Guidi, Alessandra Raimondi, Natalie Prinzi, Filippo de Braud, Sara Pusceddu. The Role of Mesothelin as a Diagnostic and Therapeutic Target in Pancreatic Ductal Adenocarcinoma: A Comprehensive Review. Targeted Oncology 2018; 13(3): 333 doi: 10.1007/s11523-018-0567-0
|
| 31 |
Suresh Chava, Meher B. Gayatri, Aramati B.M. Reddy. Breaking Tolerance to Pancreatic Cancer Unresponsiveness to Chemotherapy. 2019; : 25 doi: 10.1016/B978-0-12-817661-0.00003-2
|
| 32 |
Bo-Kyeong Jung, Hae Young Ko, Hyunji Kang, JinWoo Hong, Hyo Min Ahn, Youjin Na, Hyeongi Kim, Jin Su Kim, Chae-Ok Yun. Relaxin-expressing oncolytic adenovirus induces remodeling of physical and immunological aspects of cold tumor to potentiate PD-1 blockade. Journal for ImmunoTherapy of Cancer 2020; 8(2): e000763 doi: 10.1136/jitc-2020-000763
|
| 33 |
Wen-Jie Wang, Han Wang, Ting-Yan Hua, Wei Song, Jie Zhu, Jing-Jing Wang, Yue-Qing Huang, Zhi-Liang Ding. Establishment of a Prognostic Model Using Immune-Related Genes in Patients With Hepatocellular Carcinoma. Frontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.00055
|
| 34 |
Elisabeth Hessmann, Soeren M. Buchholz, Ihsan Ekin Demir, Shiv K. Singh, Thomas M. Gress, Volker Ellenrieder, Albrecht Neesse. Microenvironmental Determinants of Pancreatic Cancer. Physiological Reviews 2020; 100(4): 1707 doi: 10.1152/physrev.00042.2019
|
| 35 |
Sumit Kumar, Mark J A Schoonderwoerd, Jessie S Kroonen, Ilona J de Graaf, Marjolein Sluijter, Dina Ruano, Román González-Prieto, Matty Verlaan-de Vries, Jasper Rip, Ramon Arens, Noel F C C de Miranda, Lukas J A C Hawinkels, Thorbald van Hall, Alfred C O Vertegaal. Targeting pancreatic cancer by TAK-981: a SUMOylation inhibitor that activates the immune system and blocks cancer cell cycle progression in a preclinical model. Gut 2022; 71(11): 2266 doi: 10.1136/gutjnl-2021-324834
|
| 36 |
Shigekazu Murakami, Ivan Nemazanyy, Shannon M. White, Hengye Chen, Chan D.K. Nguyen, Garrett T. Graham, Dieter Saur, Mario Pende, Chunling Yi. A Yap-Myc-Sox2-p53 Regulatory Network Dictates Metabolic Homeostasis and Differentiation in Kras-Driven Pancreatic Ductal Adenocarcinomas. Developmental Cell 2019; 51(1): 113 doi: 10.1016/j.devcel.2019.07.022
|
| 37 |
George Zarkavelis, Vassiliki Kotoula, Georgia-Angeliki Kolliou, Kyriaki Papadopoulou, Ioannis Tikas, Vasilios Karavasilis, Epaminontas Samantas, Christos Dervenis, Ioannis Efstratiou, Irene Nicolaou, Dimitra Apessou, Georgia Kafiri, Triantafyllia Koletsa, Iliada Bompolaki, Grigorios Rallis, Anna Batistatou, George Glantzounis, Dimitrios Pectasides, George Fountzilas, George Pentheroudakis. Genetic mapping of pancreatic cancer by targeted next-generation sequencing in a cohort of patients managed with nab-paclitaxel-based chemotherapy or agents targeting the EGFR axis: a retrospective analysis of the Hellenic Cooperative Oncology Group (HeCOG). ESMO Open 2019; 4(5): e000525 doi: 10.1136/esmoopen-2019-000525
|
| 38 |
Marina Macchini, Marta Chiaravalli, Silvia Zanon, Umberto Peretti, Elena Mazza, Luca Gianni, Michele Reni. Chemotherapy in elderly patients with pancreatic cancer: Efficacy, feasibility and future perspectives. Cancer Treatment Reviews 2019; 72: 1 doi: 10.1016/j.ctrv.2018.10.013
|
| 39 |
Weijia Wang, Liang Yan, Xiaoya Guan, Bin Dong, Min Zhao, Jianhui Wu, Xiuyun Tian, Chunyi Hao. Identification of an Immune-Related Signature for Predicting Prognosis in Patients With Pancreatic Ductal Adenocarcinoma. Frontiers in Oncology 2021; 10 doi: 10.3389/fonc.2020.618215
|
| 40 |
Jonathan J. Hue, Katherine Bingmer, Kavin Sugumar, Sarah C. Markt, Luke D. Rothermel, Jeffrey M. Hardacre, John B. Ammori, Jordan M. Winter, Lee M. Ocuin. Immunotherapy Is Associated with a Survival Benefit in Patients Receiving Chemotherapy for Metastatic Pancreatic Cancer. Journal of Pancreatic Cancer 2021; 7(1): 31 doi: 10.1089/pancan.2021.0003
|
| 41 |
Etienne D. Foucher, Clément Ghigo, Salem Chouaib, Jérôme Galon, Juan Iovanna, Daniel Olive. Pancreatic Ductal Adenocarcinoma: A Strong Imbalance of Good and Bad Immunological Cops in the Tumor Microenvironment. Frontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.01044
|
| 42 |
Arturo Orlacchio, Stephen Muzyka, Tamas A. Gonda. Epigenetic Regulation of Cancer - Part B. International Review of Cell and Molecular Biology 2024; 383: 1 doi: 10.1016/bs.ircmb.2023.10.002
|
| 43 |
Christian Benzing, Hoyin Lam, Chi Man Tsang, Alexander Rimmer, Yoana Arroyo-Berdugo, Yolanda Calle, Claire M. Wells. TIMP-2 secreted by monocyte-like cells is a potent suppressor of invadopodia formation in pancreatic cancer cells. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-6429-z
|
| 44 |
Daniela L. Papademetrio, María Noé Garcia, Daniel Grasso, Élida Alvarez. Autophagy-Mediated Exosomes as Immunomodulators of Natural Killer Cells in Pancreatic Cancer Microenvironment. Frontiers in Oncology 2021; 10 doi: 10.3389/fonc.2020.622956
|
| 45 |
Maria Auxiliadora de Paula Carneiro Cysneiros, Magno Belém Cirqueira, Lucas de Figueiredo Barbosa, Ênio Chaves de Oliveira, Lucio Kenny Morais, Isabela Jubé Wastowski, Vitor Gonçalves Floriano, Afsheen Raza. Immune cells and checkpoints in pancreatic adenocarcinoma: Association with clinical and pathological characteristics. PLOS ONE 2024; 19(7): e0305648 doi: 10.1371/journal.pone.0305648
|